We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Compugen Ltd | NASDAQ:CGEN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.98 | 1.97 | 2.00 | 0 | 10:36:50 |
(Exact name of registrant as specified in its charter)
|
||
Israel
|
N/A
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
incorporation or organization)
|
Identification No.)
|
Azrieli Center, 26 Harokmim Street, Building D
Holon, 5885849
(Address of Principal Executive Offices)
|
Not Applicable
(Zip Code)
|
Copies to:
|
||
Ari Krashin
|
Daniel I. Goldberg, Esq.
|
Eran Ben Dor
|
Compugen Ltd.
|
Cooley LLP
|
Compugen Ltd.
|
26 Harokmim Street
Building D
|
55 Hudson Yards
|
26 Harokmim Street
Building D
|
Holon, 5885849, Israel
|
New York, NY 10001-2157
|
Holon, 5885849, Israel
|
Tel: 972-3-765-8585
|
Tel: 212-479-6000
|
Tel: 972-3-765-8585
|
Fax: 972-3-765-8555
|
Fax: 212 479 6275
|
Fax: 972-3-765-8555
|
Large accelerated filer ☐
|
Accelerated filer ☒
|
Non-accelerated filer ☐
|
Smaller reporting company ☐
|
Emerging growth company ☐
|
Title of securities to be registered
|
Amount to be
registered(1)
|
Proposed maximum offering price per share
|
Proposed maximum aggregate offering price
|
Amount of
registration fee
|
||||||||||||
Ordinary Shares, nominal (par) value NIS 0.01 per share
|
5,000,000
|
(2)
|
$
|
14.23
|
(3)
|
$
|
71,125,000.00
|
(3)
|
$
|
9,232.03
|
(1) |
Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional ordinary shares nominal (par) value NIS 0.01 per share (the “Ordinary Shares”) that may
become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding Ordinary Shares of the registrant.
|
(2) |
Represents an additional 5,000,000 Ordinary Shares issuable under the Compugen Ltd. 2010 Share Incentive Plan, as amended (the “2010 Plan”), over and above the number of Ordinary Shares issuable under the 2010 Plan that were previously
registered under the Securities Act.
|
(3) |
Pursuant to Rule 457(h)(1) under the Securities Act, the proposed maximum offering price per security and the proposed maximum aggregate offering price are based on the average of the high and low sale prices per share of the registrant’s
Ordinary Shares as reported by The Nasdaq Global Market on July 24, 2020.
|
|
(i) |
The Registrant’s Annual Report on Form 20-F for the fiscal year ended December 31, 2019, filed with the Commission on February 24, 2020, as amended on February 27, 2020 (File No. 000-30902);
|
|
(ii) |
The Registrant’s Reports of Foreign Private Issuer on Form 6-K, as filed with the Commission on January 9, 2020, February 20, 2020, March 9, 2020, March 11, 2020, March 12, 2020, March 13, 2020, March 17, 2020, April 6, 2020, April 15,
2020, April 27, 2020, May 6, 2020, May 27, 2020, June 1, 2020 and July 30, 2020 (File No. 000-30902); and
|
|
(iii) |
The description of the Registrant’s Ordinary Shares in the Registrant’s Registration Statement on Form 8-A (File No. 000-30902) filed with the Commission under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on August
2, 2000, including any amendment or report filed for the purpose of updating such description.
|
EXHIBIT NO.
|
EXHIBIT
|
|
Compugen Ltd.
By: /s/ Anat Cohen-Dayag, Ph.D.
Anat Cohen-Dayag, Ph.D.
Chief Executive Officer and President
|
Signature
|
Title(s)
|
Date
|
/s/ Anat Cohen-Dayag, Ph.D.
Anat Cohen-Dayag, Ph.D.
|
Chief Executive Officer and President and Director
(principal executive officer)
|
July 30, 2020
|
/s/ Ari Krashin
Mr. Ari Krashin
|
Chief Financial Officer
(principal financial and accounting officer)
|
July 30, 2020
|
/s/ Paul Sekhri
Mr. Paul Sekhri
|
Chairman of the Board
|
July 30, 2020
|
/s/ Sandy Zweifach
Mr. Sandy Zweifach
|
Director
|
July 30, 2020
|
/s/ Dr. Jean-Pierre Bizzari
Dr. Jean-Pierre Bizzari
|
Director
|
July 30, 2020
|
/s/ Eran Perry
Mr. Eran Perry
|
Director
|
July 30, 2020
|
/s/ Gilead Halevy
Mr. Gilead Halevy
|
Director
|
July 30, 2020
|
/s/ Dr. Kinneret Livnat Savitzky
Dr. Kinneret Livnat Savitzky
|
Director
|
July 30, 2020
|
Compugen USA, Inc.
By: /s/ Julia Decker
Name: Julia Decker
Title: Treasurer and Director of Finance of Compugen USA, Inc.
|
Authorized U.S. Representative
|
July 30, 2020
|
1 Year Compugen Chart |
1 Month Compugen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions